Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
186 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01870609 | Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma(COMMAND) | terminated | Phase 2 | 344 | Verastem, Inc.INDUSTRY | 15 | Jan 30, 2017 | clinicaltrials |
| NCT01374451 | Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET(COOPERATE-2) | terminated | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 19 | Dec 20, 2016 |
| clinicaltrials |
| NCT01437566 | Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy | completed | Phase 2 | 318 | Genentech, Inc.INDUSTRY | 23 | Nov 2, 2016 | clinicaltrials |
| NCT01652482 | Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC) | completed | Phase 2 | 135 | Genentech, Inc.INDUSTRY | 10 | Nov 2, 2016 | clinicaltrials |
| NCT01559844 | Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant | completed | Phase 2 | 61 | Gilead SciencesINDUSTRY | 3 | Jul 27, 2016 | clinicaltrials |
| NCT00079482 | Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) | completed | Phase 2 | 224 | CephalonINDUSTRY | 13 | Jul 21, 2016 | clinicaltrials |
| NCT01088984 | Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia | completed | Phase 1 / Phase 2 | 43 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 12 | May 23, 2016 | clinicaltrials |
| NCT01624493 | BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients | withdrawn | Phase 1 / Phase 2 | 0 | Hoosier Cancer Research NetworkOTHER | 3 | Dec 23, 2015 | clinicaltrials |
| NCT01056341 | Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy | completed | Phase 2 / Phase 3 | 512 | Pierre Fabre DermatologyINDUSTRY | 16 | Dec 10, 2015 | clinicaltrials |
| NCT00391066 | Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)(LUCID) | terminated | Phase 2 | 627 | BiogenINDUSTRY | 23 | Oct 2, 2015 | clinicaltrials |
| NCT00427050 | A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel | completed | Phase 2 | 50 | PeplinINDUSTRY | 2 | Sep 14, 2015 | clinicaltrials |
| NCT00135577 | Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects | completed | Phase 2 | 67 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 13 | Sep 2, 2015 | clinicaltrials |
| NCT01379534 | A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer | completed | Phase 2 | 53 | Novartis PharmaceuticalsINDUSTRY | 7 | May 20, 2015 | clinicaltrials |
| NCT01791387 | 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC(DILIGENCE-1) | unknown | Phase 2 | 30 | Auckland District Health BoardOTHER_GOV | 1 | Feb 3, 2015 | clinicaltrials |
| NCT00072280 | Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma | terminated | Phase 2 | 7 | Children's Oncology GroupNETWORK | 4 | Sep 30, 2014 | clinicaltrials |
| NCT01682031 | Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy | terminated | Phase 2 | 18 | Roswell Park Cancer InstituteOTHER | 2 | Aug 22, 2014 | clinicaltrials |
| NCT00021242 | Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia | completed | Phase 2 | 12 | Children's Oncology GroupNETWORK | 7 | Aug 8, 2014 | clinicaltrials |
| NCT00002941 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma | completed | Phase 2 | 69 | Children's Oncology GroupNETWORK | 7 | Aug 1, 2014 | clinicaltrials |
| NCT00003234 | Vinorelbine in Treating Children With Recurrent or Refractory Cancers | completed | Phase 2 | 50 | Children's Oncology GroupNETWORK | 7 | Jul 28, 2014 | clinicaltrials |
| NCT00003178 | Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia | completed | Phase 2 | 120 | Children's Oncology GroupNETWORK | 7 | Jul 25, 2014 | clinicaltrials |
| NCT01631279 | A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors | terminated | Phase 1 / Phase 2 | 33 | Proacta, IncorporatedINDUSTRY | 2 | Jun 16, 2014 | clinicaltrials |
| NCT00028795 | Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma | completed | Phase 2 | 170 | Children's Oncology GroupNETWORK | 7 | Feb 21, 2014 | clinicaltrials |
| NCT00006462 | Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia | completed | Phase 2 | 32 | Children's Oncology GroupNETWORK | 7 | Feb 20, 2014 | clinicaltrials |
| NCT00003955 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma | completed | Phase 2 | 77 | Children's Oncology GroupNETWORK | 7 | Feb 14, 2014 | clinicaltrials |
| NCT00463788 | Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer(BALI-1) | completed | Phase 2 | 181 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 11 | Feb 13, 2014 | clinicaltrials |
| NCT00003175 | Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer | completed | Phase 2 | 45 | Medical Research CouncilOTHER_GOV | 8 | Dec 4, 2013 | clinicaltrials |
| NCT00019422 | Lobradimil and Carboplatin in Treating Children With Brain Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 7 | Aug 16, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00003745 | Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas | completed | Phase 2 | 125 | National Cancer Institute (NCI)NIH | 7 | Feb 5, 2013 | clinicaltrials |
| NCT00006102 | Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 2 | 200 | National Cancer Institute (NCI)NIH | 7 | Feb 5, 2013 | clinicaltrials |
| NCT00862134 | Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 2 | 42 | Proacta, IncorporatedINDUSTRY | 3 | Jan 10, 2013 | clinicaltrials |
| NCT00835419 | Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression(ENVER) | completed | Phase 2 | 12 | Piramal Enterprises LimitedINDUSTRY | 3 | Dec 4, 2012 | clinicaltrials |
| NCT01034410 | A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia | terminated | Phase 2 | 90 | Antisoma ResearchINDUSTRY | 4 | Feb 2, 2011 | clinicaltrials |
| NCT00512083 | Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia | completed | Phase 2 | 70 | Antisoma ResearchINDUSTRY | 2 | Sep 25, 2009 | clinicaltrials |
| NCT00072852 | Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine | completed | Phase 2 | 134 | PfizerINDUSTRY | 5 | Oct 16, 2008 | clinicaltrials |
| NCT00294359 | The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer | completed | Phase 2 / Phase 3 | 333 | Australasian Gastro-Intestinal Trials GroupNETWORK | 2 | Aug 22, 2007 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials